EBD Group is part of the Knowledge and Networking Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa
Key Sessions

Anna Turetsky

Company creation: Does in-house formation outweigh traditional investments for VCs?

Lightstone Ventures

Jerome M. Adams, MD, MPH,

Xcelerate Keynotes

US Department of Health and Human Services

7:30am - 8:00am 30 mins
Main Agenda
Registration and Exhibition // Open all day
more

The registration desk and exhibition will be open all day.

7:30am - 8:30am 60 mins
Networking
Continental Breakfast
8:00am - 6:00pm 600 mins
Main Agenda
One-to-one meetings
8:30am - 9:15am 45 mins
Therapeutic Spotlight
Advances in rare disease
8:30am - 9:15am 45 mins
EBD Academy
EBD Academy Buzz session: Mastering the fund raise pitch to investors
  • Speaker Joe Dillon - President and CEO, Dillon Capital Strategies
more

This session is designed to help company executives involved in fund raising to create pitches that have the potential to attract investors and reduce the time it takes to secure funding. Successful pitches rely on many factors beyond communicating the science. During this session we will explore proven pitch tactics that can differentiate your opportunity from the many others investors see every day.

What we will cover:
•        The top 5 things investors look for first in a pitch
•        The top 5 things that turn investors off right away
•        Knowing your audience – pitch customizing
•        What to communicate and when – before and after CDA
•        Selling optimism while maintaining credibility
•        Maintaining momentum after the first pitch
•        Group discussion – sharing pitch experiences

9:15am - 10:15am 60 mins
Therapeutic Spotlight
Company presentations
9:30am - 10:15am 45 mins
Strategy and Business
Company creation: Does in-house formation outweigh traditional investments for VCs?
  • Panelist Anna Turetsky - VP, Lightstone Ventures
  • Panelist Michael Gladstone - Principal, Atlas Venture
more

Recently, traditional VCs are taking company creation into their own hands instead of making traditional investments in new technologies and companies. Why is this happening? Is it a lack of good ideas coming out of biotech companies? A lack of quality management? Is this becoming the new normal and preferred route for VCs? Hear from this panel on recent trends in company creation versus traditional investments and how it is affecting the ecosystem.

10:15am - 12:15pm 120 mins
Pitch and Partner
Company presentations
10:30am - 11:15am 45 mins
Therapeutic Spotlight
Big bets in underrepresented therapeutic areas
  • Panelist Joep Muijrers - CFO, PureTech Health
more

Every pharma company prides themselves on being innovation-driven, yet the majority of their R&D targets and approaches are in the same therapeutic areas. Sit down with industry executives to discuss why going into unpopular areas alone can actually be wildly successful.

11:15am - 12:15pm 60 mins
Therapeutic Spotlight
Company presentations
12:15pm - 1:15pm 60 mins
Networking
Luncheon
1:15pm - 2:00pm 45 mins
Strategy and Business
Live recording of "The Readout LOUD" podcast with STAT
  • Speaker Adam Feuerstein - Senior Writer, Biotech, STAT
  • Speaker Damian Garde - National Biotech Reporter, STAT
  • Speaker Rebecca Robbins - Business Reporter, STAT
more

Join the STAT biotech team for the first ever live recording of "The Readout LOUD" — STAT's weekly biotech podcast, breaking down the latest news, digging deep into industry goings-on, and giving you a preview of the week to come.

1:15pm - 2:00pm 45 mins
Therapeutic Spotlight
Partnering in oncology
  • Moderator Philip Kenner - Principal, ClearView Healthcare Partners
  • Panelist Christiana Bardon - Managing Director, Burrage Capital and MPM Capital, Oncology Impact Fund
  • Panelist Jonathan Lanfear - VP, Head of Oncology and Neuroscience Business Development, Takeda
  • Panelist Philippe Lopes-Fernandes - Senior VP, Global Head of Business Development & Alliance Management, Merck KGaA, Darmstadt, Germany
  • Panelist Patrick Tricoli - CEO, Nanobiotix USA
more
2:00pm - 3:00pm 60 mins
Therapeutic Spotlight
Company presentations
3:30pm - 5:30pm 120 mins
Xcelerate Keynote Series
Xcelerate Keynotes
  • Speaker Jerome M. Adams, MD, MPH, - US Surgeon General, US Department of Health and Human Services
  • Speaker Alexis Borisy - Partner, Third Rock Ventures; Chair, National Venture Capital Association, Third Rock Ventures
  • Speaker Susan Hockfield - President Emerita and Professor of Neuroscience, MIT
  • Speaker Elizabeth Nabel - President, Brigham Health
  • Speaker George Yancopoulos - President and Chief Scientific Officer, Regeneron Pharmaceuticals
more

Presented by Xconomy, Xcelerate features a curated series of spotlight keynotes from life science luminaries that will capture the attention of the entire festival. As life sciences, healthcare and drug development are undergoing unprecedented change, including the arrival of groundbreaking new treatments and the growing backlash against high drug prices, the keynote speakers will share insights on how their areas of life science and healthcare are adapting to all this change, and what other disruptive forces they see on the horizon.

Showing of Streams